Latest News

EARLY PROMISING DATA FROM THE PHASE 2 CLINICAL TRIAL OF THE VAXINE-CINNAGEN COVID-19 VACCINE

CinnaGen Co. announced that the results of preliminary analysis of data from the ongoing Phase 2 human clinical trial of the Vaxine-originated COVID-19 vaccine candidate were positive. This potential vaccine comprises a recombinant spike protein antigen formulated with Vaxine’s proprietary Advax-SM adjuvant. The Phase 2 study was a randomized, double-blind, placebo-controlled trial conducted in Iran on […]

Can India prevent COVID-19 third wave? Global vaccine expert Professor Nikolai Petrovsky answers

TV9 News spoke to Prof Nikolai Petrovsky, PhD, senior researcher, an expert on vaccine development and director of endocrinology at Flinders medical centre, Flinders University, Australia, to understand the importance of stringent lockdown measures and what can India learn from Australia’s handling of the COVID-19 pandemic. Here is the link to the full article: https://tv9news.com/india/can-india-prevent-covid-19-third-wave-global-vaccine-expert-answers-42504.html […]

Our modeling paper “In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin”

Our Modeling paper on the origins of SARS-CoV-2 just got published by Nature Scientific Reports. If you would like to read and download the full paper, use the following link https://www.nature.com/articles/s41598-021-92388-5